A Study to Evaluate the Drug-drug Interaction and Safety Between HCP1306, RLD2302 and RLD2102 in Healthy Volunteers

NCT06518122 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

66

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: HCP1306
DRUG: RLD2302
DRUG: RLD2102

Sponsor

Hanmi Pharmaceutical Company Limited